Thermosome is a pioneering brand in the field of targeted tumor therapy, combined with immune stimulation, to revolutionize cancer treatment. With a focus on improving clinical efficacy, Thermosome has developed a unique tumor targeting concept that enables higher drug concentrations in local areas, resulting in enhanced treatment outcomes for patients. At the heart of Thermosome's approach is their cutting-edge pipeline, which is dedicated to redefining the standard of care for locally advanced soft tissue sarcoma.

Through their innovative research and development efforts, they are continuously striving to create best-in-class, TSL-based tumor targeting solutions. Behind this remarkable brand is a team of experienced biotech entrepreneurs who are dedicated to driving breakthroughs in cancer therapy. With their expertise and commitment, Thermosome is at the forefront of advancing the field of targeted tumor therapy.

Stay updated with the latest news and events from Thermosome, including their participation in the IMAGIO Consortium to improve cancer treatment and the dosing of their lead program, THE001. Join them in their mission to transform cancer therapy and learn more about the science behind their tumor targeting concept. For more information, contact Thermosome at info@thermosome.

com or visit their headquarters in Planegg, Germany